FDA Approves Absurd Pill to Delay Diabetes
A monoclonal antibody injection has been approved for Type 1 diabetes. It only costs about $200K and comes with a risk of serious side effects.
STORY AT-A-GLANCE
The U.S. Food and Drug Administration approved Tzield (teplizumab-mzwv), made by drugmakers Sanofi and Provention Bio, for use in adults and children 8 years and older who have stage 2, Type 1 diabetes
Tzield is a monoclonal antibody injection that neither treats nor prevents Type 1 diabetes
The treatment is intended to delay the onset of…
Keep reading with a 7-day free trial
Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.